Browsing by AJOU Author : 강석윤

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 60 of 73

Pub YearTitleAJOU
Author
2018469: Therapy-induced senescence associated secretory phenotype enhances breast cancer cell invasion and stemness via CXCR1/2-CXCR1/2 ligands axis최용원박태준,안미선이현우,정성현강석윤,박준성최진혁
20135-Fluorouracil, mitomycin-c, and polysaccharide-k versus uracil-ftorafur and polysaccharide-K as adjuvant chemoimmunotherapy for patients with locally advanced gastric cancer with curative resection.안미선강석윤,이현우정성현,박준성이광재,조용관한상욱,이순영최진혁
2009A case of bladder rhabdomyosarcoma in an adult최용원김세중,주희재강석윤
2010A case of donor-derived granulocytic sarcoma after allogeneic hematopoietic stem cell transplantation정성현한재호,정선용강석윤,이현우최진혁,박준성
2009A case of head and neck rhabdomyosarcoma with pancreatic metastasis최용원안미선,한재호강석윤
2009A Case Report of Helicobacter Pylori Negative Gastric MALT Lymphoma with Monoclonal Gammopathy정성현이현우,강석윤최진혁,한재호김장희,김명욱유병무,박준성
2016A Korean Nationwide Survey for Breakthrough Cancer Pain in an Inpatient Setting강석윤
2016A multicenter phase II study of sorafenib in combination with erlotinib in patients with advanced non-small cell lung cancer (KCSG-0806)강석윤최진혁
2011A novel algorithm for detection of adverse drug reaction signals using a hospital electronic medical record database이기영강석윤,박인휘감혜진,박래웅
2013A randomized, multi-center, open-label, phase II study of once-per-cycle DA-3031, a biosimilar pegylated G-CSF, compared with daily filgrastim in patients receiving TAC chemotherapy for early-stage breast cancer.강석윤
2017A randomized, multi-center, open-label, phase III study of once-per-cycle DA-3031, a pegylated G-CSF, in comparison with daily filgrastim in patients receiving TAC chemotherapy for breast cancer강석윤
2019Abrogation of B-Raf(V600E) induced senescence by FoxM1 expression최용원김장희,강석윤박태준
2012Acquired hemophilia successfully treated with activated prothrombin complex concentrate and immunosuppressant combination: a case report안미선정성현,박준성강석윤,최진혁이현우
2017Adjuvant concurrent chemoradiotherapy with low-dose daily cisplatin for extrahepatic bile duct cancer노오규김지훈,전미선오영택,강석윤이현우,박래웅윤덕용
2007Aging Effects on Dendritic Cells after Total Body Irradiation in Mice정성현이현우,강석윤최진혁,김효철박준성
2018Attenuated FOLFIRINOX in the salvage treatment of gemcitabine-refractory advanced pancreatic cancer: a phase II study이현우강석윤
2011Bax predicts outcome in gastric cancer patients treated with 5-fluorouracil, leucovorin, and oxaliplatin palliative chemotherapy.정성현한재호,김장희안미선,이현우강석윤,박준성최진혁,이광재신승수
2016Circulating Plasma Biomarkers for TSU-68, an Oral Antiangiogenic Agent, in Patients with Metastatic Breast Cancer강석윤
2009Clinical Significance of Co-expression of Aberrant Antigens in Acute Leukemia정성현이현우,안미선강석윤,최진혁김효철,조성란박준성
2014Clinical significance of cryptic chromosomal translocations detected by multiplex RT-PCR in patients with acute leukemia.박준성최진혁,강석윤이현우,안미선조성란,정성현
2014Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline: randomized phase II multicenter trial.강석윤
2008Comparison of multiplex reverse transcription polymerase chain reaction and conventional cytogenetics as a diagnostic strategy for acute leukemia.박준성정성현,이현우강석윤,최진혁김효철,박준은임영애,김현주조성란
2013Comparison of neoadjuvant adriamycin and docetaxel versus adriamycin, cyclophosphamide followed by paclitaxel in patients with operable breast cancer.전자영강석윤,정용식김지영,안미선강두경,김태희임현이,안영실박래웅,김구상
2016Comparison of Treatment Outcomes between Breast Conserving Surgery Followed by Radiotherapy and Mastectomy Alone in Patients with T1-2 Stage and 1-3 Axillary Lymph Nodes in the Era of Modern Adjuvant Systemic Treatments김상원전미선,한세환정용식,최진혁강석윤
2006Concurrent chemoradiotherapy in patients with nasopharyngeal cancer: prognostic significance of low expression of bax.강석윤오영택,한재호최진혁,이현우장준호,박준성김효철,강승희전미선,김철호주희재
2009Concurrent Chemoradiotherapy with Weekly Paclitaxel for Locally Advanced Non-small Cell Lung Cancer정성현이현우,강석윤안미선,오영택최진혁,신승수박광주
2009Difference in Viability of CD34+ Cells in Cryopreserved Cord Blood According to Evaluation Methods박준성최진혁,강석윤이현우,김효철정성현
2012Differential diagnosis in idiopathic granulomatous mastitis and tuberculous mastitis임현이김태희,강두경오기근,강석윤안영실,전미선박래웅,정용식김구상
2015Does the timing of adjuvant chemotherapy for gastric cancer influence patient outcome?강석윤안미선,최용원이현우,정성현박준성,조용관한상욱,신승수한재호,최진혁
2018Efficacy and safety findings from DREAM: a phase III study of DHP107 (oral paclitaxel) versus i.v. paclitaxel in patients with advanced gastric cancer after failure of first-line chemotherapy강석윤
2018EGFR Exon 19 Deletion is Associated With Favorable Overall Survival After First-line Gefitinib Therapy in Advanced Non-Small Cell Lung Cancer Patients최용원이현우,정성현강석윤,박준성최진혁,고영화한재호,신승수
2007Endothelial progenitor cell differentiation using cryopreserved, umbilical cord blood-derived mononuclear cells.이현우강석윤,박준성최진혁,김효철
2010Expression of Bcl-2 predicts outcome in locally advanced non-small cell lung cancer patients treated with cisplatin-based concurrent chemoradiotherapy.정성현한재호,김장희이현우,강석윤최진혁,오영택전미선,박광주황성철,신승수
2009Expression of excision repair cross-complementation group 1 protein predicts poor outcome in advanced non-small cell lung cancer patients treated with platinum-based doublet chemotherapy.이현우한재호,김장희정재호,정성현강석윤,최진혁오영택,박광주황성철,신승수
2008Expression of excision repair cross-complementation group 1 protein predicts poor outcome in patients with small cell lung cancer.이현우한재호,김장희정성현,강석윤최진혁,오영택박광주,황성철신승수
2001Factors Affecting Mobilization and Engraftment in High Dose Chemotherapy with Fixed Dose of Glycosylated rHuG-CSF(Lenograstim)강석윤
2017Feasibility and Efficacy of Eribulin Mesilate in Korean Patients with Metastatic Breast Cancer: Korean Multi-center Phase IV Clinical Study Results강석윤
2013Gankyrin is frequently overexpressed in breast cancer and is associated with ErbB2 expression.김장희임현이,강석윤정용식,박태준
2013Granulocytic sarcoma in breast after bone marrow transplantation.정성현강석윤,김태희강두경,임현이정용식,김구상
2012Helicobacter pylori infection as an independent prognostic factor for locally advanced gastric cancer patients treated with adjuvant chemotherapy after curative resection강석윤한재호,안미선이현우,정성현박준성,조용관한상욱,김영배김장희,신승수최진혁
2016High expression of Bcl-2 predicts poor outcome in diffuse large B-cell lymphoma patients with low international prognostic index receiving R-CHOP chemotherapy최용원안미선,최진혁이현우,강석윤정성현,박준성한재호,김장희신승수
2010High expression of excision repair cross-complementation group 1 protein predicts poor outcome in patients with nasopharyngeal cancer.이현우한재호,최진혁강석윤,정성현안미선,오영택김장희,김철호신승수
2015Is fourth-line chemotherapy routine practice in advanced non-small cell lung cancer?최용원안미선,이현우정성현,강석윤박준성,최진혁이순영
2007Low expression of Bax predicts poor prognosis in patients with locally advanced esophageal cancer treated with definitive chemoradiotherapy.강석윤한재호,이광재최진혁,이현우박준성,김효철강승희,오영택전미선,김장희신승수
2008Low expression of Bax predicts poor prognosis in resected non-small cell lung cancer patients with non-squamous histology.정성현이현우,한재호강석윤,최진혁최호,오영택박광주,황성철신승수,김장희
2012Magnetic resonance imaging patterns of tumor regression after neoadjuvant chemotherapy in breast cancer patients: correlation with pathological response grading system based on tumor cellularity김태희강두경,임현이정용식,김구상강석윤
2015Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer.강석윤
2017Multicenter, cross-sectional observational study of the impact of neuropathic pain on quality of life in cancer patients강석윤
2013Multicentre phase II trial of bevacizumab combined with docetaxel-carboplatin for the neoadjuvant treatment of triple-negative breast cancer (KCSG BR-0905).강석윤
2015Oral Maintenance Chemotherapy with 6-Mercaptopurine and Methotrexate in Patients with Acute Myeloid Leukemia Ineligible for Transplantation.최용원정성현,안미선이현우,강석윤최진혁,박준성
2009Outcome of Locally Advanced Esophageal Cancer Treated with Concurrent Chemo-radiotherapy강승희오영택,전미선최진혁,강석윤
2014Patterns of neutropenia and risk factors for febrile neutropenia of diffuse large B-cell lymphoma patients treated with rituximab-CHOP.최용원정성현,안미선이현우,강석윤최진혁,박준성
2019Pertuzumab, trastuzumab, and docetaxel for HER2-positive early or locally advanced breast cancer in the neoadjuvant setting: Efficacy and safety analysis of a randomized phase III study in Asian patients (PEONY)강석윤
2013Phase III, multicenter, randomized trial of maintenance chemotherapy versus observation in patients with metastatic breast cancer after achieving disease control with six cycles of gemcitabine plus paclitaxel as first-line chemotherapy: KCSG-BR07-02.강석윤
2018Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in gastric cancer patients who underwent palliative chemotherapy강석윤최용원,안미선이현우,최진혁
2017Prognostic utility of FDG PET/CT and bone scintigraphy in breast cancer patients with bone-only metastasis윤준기이수진,강석윤임현이,안영실
2016Prognostic Value of Axillary Nodal Ratio after Neoadjuvant Chemotherapy of Doxorubicin/Cyclophosphamide Followed by Docetaxel in Breast Cancer: A Multicenter Retrospective Cohort Study강석윤
2015Quality of life (QoL) in metastatic breast cancer patients with maintenance paclitaxel plus gemcitabine (PG) chemotherapy: results from phase III, multicenter, randomized trial of maintenance chemotherapy versus observation (KCSG-BR07-02).강석윤
2012Risk Reducing Surgery in Carriers with Double Heterozygosity for BRCA1 and BRCA2 Mutations홍우성김구상,정용식강석윤,강두경김태희,임현이전미선,박명철장석준
2019S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial강석윤
1 2

Browse